1.Barbituratesarefarsaferforusethanbenzodiazepines.
a.True
b.False
ANSWER: False
POINTS: 1
REFERENCES: SubjectiveEffectsofBenzodiazepinesatNormalDosageLevels
QUESTIONTYPE: True/False
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3b-Therangeofpopulationsservedandneedsaddressed
byhumanservices.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
2.Benzodiazepinesarerarelyinjectedintomuscletissueduetotheirerraticabsorption.Oneexceptiontothisiswhena
patientisexperiencing
a.aheartattack.
b.anoverdoseofheroin.
c.deliriumtremors.
d.aseizure.
ANSWER: d
POINTS: 1
REFERENCES: ThePharmacologyoftheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
3.Theeffectsofwhichneurotransmitterareenhancedbytheuseofbenzodiazepines?of
a.glutamate.
b.GABA.
c.norepinephrine.
d.endorphins.
ANSWER: b
POINTS: 1
REFERENCES: ThePharmacologyoftheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
thataffecthumandevelopment,functioning,andbehavior
UnitedStates-CSHSE.2a-Theoriesofhumandevelopment.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
4.Themedicalcommunitycollectivelyusesbenzodiazepinesforthetreatmentofchronic,orlong-term,anxiety.
a.True
b.False
ANSWER: False
POINTS: 1
REFERENCES: Side-EffectsoftheBenzodiazepinesWhenUsedAtNormalDosageLevels
QUESTIONTYPE: True/False
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3c-Themajormodelsusedtoconceptualizeandintegrate
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
5.TheRoyalCollegeofPsychiatristsinGreatBritainrecommendsthatbenzodiazepinesbeusedonacontinualbasisfor
nolongerthan________.
a.4weeks
b.8weeks
c.6months
d.12months
ANSWER: a
POINTS: 1
REFERENCES: Neuroadaptationto,Abuseof,andAddictiontotheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.04-Describeneuroadaptationtobenzodiazepines
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3c-Themajormodelsusedtoconceptualizeandintegrate
prevention,maintenance,intervention,rehabilitation,andhealthyfunctioning.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
6.Acommonformofbenzodiazepineabuseiswhentheyaremixedwith_______toproduceasenseofeuphoria.
a.anabolicsteroids
b.barbiturates
c.methadone
d.marijuana
ANSWER: c
POINTS: 1
REFERENCES: Neuroadaptationto,Abuseof,andAddictiontotheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.04-Describeneuroadaptationtobenzodiazepines
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
7.Itispotentiallydangeroustomixbenzodiazepineswithmanyprescriptionandover-the-counterdrugsorherbal
supplements.
a.True
b.False
ANSWER: True
POINTS: 1
REFERENCES: Neuroadaptationto,Abuseof,andAddictiontotheBenzodiazepines
QUESTIONTYPE: True/False
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.04-Describeneuroadaptationtobenzodiazepines
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
thataffecthumandevelopment,functioning,andbehavior
UnitedStates-CSHSE.3b-Therangeofpopulationsservedandneedsaddressed
byhumanservices.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
8.Whichhypnoticdrugworksbybindingwiththemelatoninreceptorinthebrain?
a.Zolpidem
b.Buspirone
c.Ramelteon
d.Rohypnol
ANSWER: c
POINTS: 1
REFERENCES: TheBenzodiazepineReceptorAntagonists(Z-CompoundsorBRAs)
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.05-Describethebenzodiazepinereceptorantagonists
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
thataffecthumandevelopment,functioning,andbehavior
UnitedStates-CSHSE.3c-Themajormodelsusedtoconceptualizeandintegrate
prevention,maintenance,intervention,rehabilitation,andhealthyfunctioning.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
9.Thebenzodiazepinesaresaidto
a.artificiallysimulatetheeffectsofGABAatthereceptorsite.
b.blocktheeffectsofGABAatthereceptor.
c.makethereceptorsitemoresensitivetoGABAmolecules.
d.activateproductionofmoreGABAmolecules.
ANSWER: c
POINTS: 1
REFERENCES: ThePharmacologyoftheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
thataffecthumandevelopment,functioning,andbehavior
UnitedStates-CSHSE.2a-Theoriesofhumandevelopment.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
10.Thevariationsinchemicalstructurebetweendifferentbenzodiazepines
a.affectsthedurationofaction.
b.affectstheirbindingsitewithinthebrain.
c.determinestheproductioncostsforthatspecificbenzodiazepine.
d.eliminatesorfacilitatestheprocessoflipidbindingforthatchemical.
ANSWER: a
POINTS: 1
REFERENCES: ThePharmacologyoftheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
11.Todate,researchershaveidentified_______subtypesoftheGABAreceptor,andtheexactfunctionofeach
__________.
a.morethan20;isstillbeingexplored
b.morethan20;hasbeenidentified
c.between12and15;hasbeengeneticallyisolated
d.lessthan20;isstillbeingexplored
ANSWER: a
POINTS: 1
REFERENCES: ThePharmacologyoftheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
thataffecthumandevelopment,functioning,andbehavior
UnitedStates-CSHSE.2a-Theoriesofhumandevelopment.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
12.Thebenzodiazepinesarethoughttoexerttheirprimaryeffectinthe
a.GABAfreceptorsite.
b.GABAareceptorsite.
c.GABAcreceptorsinthedescendingfibersofthemesocorticalsystem.
d.GABAbreceptorsitesintheopticlobe.
ANSWER: b
POINTS: 1
REFERENCES: ThePharmacologyoftheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
thataffecthumandevelopment,functioning,andbehavior
UnitedStates-CSHSE.2a-Theoriesofhumandevelopment.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
13.Personstakingdiazepamhavebeenfoundtohavea500%increasedchanceof
a.opticneuritis.
b.shortenedreactiontime.
c.motorvehicleaccidents.
d.increasedvisualperceptionindimlightsituations.
ANSWER: c
POINTS: 1
REFERENCES: Side-EffectsoftheBenzodiazepinesWhenUsedAtNormalDosageLevels
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3c-ethicalandculturallyrelevantstrategiesfor
conducting,interpreting,andreportingtheresultsofresearchand/orprogram
evaluation
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
14.Afriendstartedtakingaprescribedbenzodiazepineforanxietyandbeginstodemonstratesymptomsofdepression
andsuicidalthinking.Whichofthefollowingstatementsismosttrue?
a.Hisbenzodiazepineusemighthave“unmasked”ahypomanicstate.
b.Thesesymptomspossiblycouldreflectararesideeffectofthisclassofmedications.
c.Hehasdevelopedatoleranceforthismedicationanditseffects.
d.Thesesymptomsareacommonsideeffectwiththisclassofmedications.
ANSWER: b
POINTS: 1
REFERENCES: SubjectiveEffectsofBenzodiazepinesatNormalDosageLevels
QUESTIONTYPE: MultipleChoice
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
15.Whenusedatnormaldoses,whichofthefollowingisNOTapotentialsideeffectofthebenzodiazepines?
a.Enhancedneurocognitivefunction
b.Anterogradeamnesia
c.Paradoxicalragereactions
d.reboundinsomnia
ANSWER: a
POINTS: 1
REFERENCES: SideEffectsoftheBenzodiazepinesWhenUsedAtNormalDosageLevels
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3d-Economicandsocialclasssystemsincludingsystemic
causesofpoverty.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
16.Benzodiazepineshavebeenfoundto____________insomeusers.
a.increasestage1and2sleepwhenstarted
b.decreasestage1and2sleepwhenstarted
c.causereboundinsomniawhendiscontinued
d.increaseREMsleeptime
ANSWER: c
POINTS: 1
REFERENCES: SideEffectsoftheBenzodiazepinesWhenUsedAtNormalDosageLevels
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
17.Heroinabuserswillmostcommonlyuselargedosesofabenzodiazepineto
a.enjoytheeffectsofheroinforalongerperiodoftimeastheygrowolder.
b.mitigatewithdrawaleffectsfromalcoholduringtheworkday.
c.treatmusclesprains.
d.distractthemselvesfromboring,routinetaskssuchaslongdistancedriving.
ANSWER: b
POINTS: 1
REFERENCES: Neuroadaptationto,Abuseof,andAddictiontotheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.04-Describeneuroadaptationtobenzodiazepines
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
thataffecthumandevelopment,functioning,andbehavior
UnitedStates-CSHSE.3b-Therangeofpopulationsservedandneedsaddressed
byhumanservices.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
18.Accordingtoyourtext,flunitrazepam(Rohypnol®)isabout
a.10timesaspotentasdiazepam.
b.halfaspotentasdiazepamunlessmixedwithalcohol.
c.threetimesaspotentasdiazepam.
d.100timesaspotentasdiazepam.
ANSWER: a
POINTS: 1
REFERENCES: TheBenzodiazepineReceptorAntagonists(Z-CompoundsorBRAs)
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.05-Describethebenzodiazepinereceptorantagonists
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3c-Themajormodelsusedtoconceptualizeandintegrate
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
19.Thepatientwhoisprescribedbuspironeshouldnotexpectto
a.avoiddrinkinggrapefruitjuice.
b.experiencethepeakeffectsin2.5hours.
c.beabletodosejustoncedaily.
d.havetotakeadose3timesaday.
ANSWER: c
POINTS: 1
REFERENCES: TheBenzodiazepineReceptorAntagonists(Z-CompoundsorBRAs)
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.05-Describethebenzodiazepinereceptorantagonists
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.2a-Theoriesofhumandevelopment.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
20.Thepeakeffectsofzaleplonappear
a.inthelast3hoursofthenight’ssleep.
b.inthefirst4hoursafteringestion.
c.intheincreasedtimespentasleep.
d.duringREMsleep.
ANSWER: b
POINTS: 1
REFERENCES: TheBenzodiazepineReceptorAntagonists(Z-CompoundsorBRAs)
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.05-Describethebenzodiazepinereceptorantagonists
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
thataffecthumandevelopment,functioning,andbehavior
UnitedStates-CSHSE.3c-Themajormodelsusedtoconceptualizeandintegrate
prevention,maintenance,intervention,rehabilitation,andhealthyfunctioning.
DATEMODIFIED: 2/23/20188:34AM
DATECREATED: 2/21/20181:47PM
21.Benzodiazepinecaninterferewith
a.sexualfunction.
b.sleep.
c.memory.
d.alloftheseanswers.
ANSWER: d
POINTS: 1
REFERENCES: SideEffectsoftheBenzodiazepinesWhenUsedAtNormalDosageLevels
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3d-Economicandsocialclasssystemsincludingsystemic
causesofpoverty.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
22.AllofthefollowingdescribebenzodiazepinesEXCEPT
a.theyhavealargetherapeuticwindow.
b.allareproventoassistinseizurecontrol.
c.theyrequireGABAmoleculestobeatreceptorsitetobeeffective.
d.theyareoccasionallyusedasadjuncttotreatmentofanxiety.
ANSWER: b
POINTS: 1
REFERENCES: ThePharmacologyoftheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
23.Benzodiazepineover-sedationusuallyis
a.notcommonlyencounteredwhenthepersonstartstotakeoneofthesemedications.
b.commonlyencounteredwhenthepersonstartstotakeoneofthesemedications.
c.ameasureoftheindividual’svulnerabilitytothedevelopmentofphysicaladdictiontooneofthesecompounds.
d.asuresignofcrosstolerancetootherCNSdepressantssuchasalcoholorantihistamines.
ANSWER: a
POINTS: 1
REFERENCES: SubjectiveEffectsofBenzodiazepinesatNormalDosageLevels
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3b-Therangeofpopulationsservedandneedsaddressed
byhumanservices.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
24.Thebrainconstantlyattemptstoadjusttoenvironmentaldemandsthroughanumberofcompensatorymechanisms,
including
a.maintenanceofconsistentbloodsuppliestoallpartsoftheamygdala.
b.maintenanceofneurotransmittersiteresponsivenessforNMDA.
c.neural-definitation.
d.neuroadaptation.
ANSWER: d
POINTS: 1
REFERENCES: Neuroadaptationto,Abuseof,andAddictiontotheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.04-Describeneuroadaptationtobenzodiazepines
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3b-Therangeofpopulationsservedandneedsaddressed
byhumanservices.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
25.Thebenzodiazepinewithdrawalsyndrome
a.isuncomfortablebuttolerableandnotdangerous.
b.holdsthepotentialtobelifethreatening.
c.usuallycanbecarriedoutin6-12days,atmost.
d.doesnotusuallyinvolvetheuseofagradual“taper”fromthepatient’spriordose.
ANSWER: b
POINTS: 1
REFERENCES: Neuroadaptationto,Abuseof,andAddictiontotheBenzodiazepines
QUESTIONTYPE: MultipleChoice
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.04-Describeneuroadaptationtobenzodiazepines
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3b-Therangeofpopulationsservedandneedsaddressed
byhumanservices.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
26.Describethenatureofthedebateregardingthelong-termefficacyofbenzodiazepinesasanxiolytics.
ANSWER: Noanswerprovided.
POINTS: 1
REFERENCES: ThePharmacologyoftheBenzodiazepines
QUESTIONTYPE: Essay
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.02-Understandthepharmacology,subjectiveeffects,and
complicationsofbenzodiazepinesatappropriateprescribedlevels
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3c-Themajormodelsusedtoconceptualizeandintegrate
prevention,maintenance,intervention,rehabilitation,andhealthyfunctioning.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
27.Discussseveralmedicalusesofbenzodiazepines.
ANSWER: Noanswerprovided.
POINTS: 1
REFERENCES: MedicalUsesofBenzodiazepines
QUESTIONTYPE: Essay
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.01-Understandthehistoryofbenzodiazepines
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3c-Themajormodelsusedtoconceptualizeandintegrate
prevention,maintenance,intervention,rehabilitation,andhealthyfunctioning.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
28.Whataresomeofthelong-termconsequencesofchronicbenzodiazepineuse?
ANSWER: Noanswerprovided.
POINTS: 1
REFERENCES: Neuroadaptationto,Abuseof,andAddictiontotheBenzodiazepines
QUESTIONTYPE: Essay
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.04-Describeneuroadaptationtobenzodiazepines
NATIONALSTANDARDS: UnitedStates-CACREP.3D-Theoriesandetiologyofaddictionsandaddictive
behaviors
UnitedStates-CSHSE.3b-Therangeofpopulationsservedandneedsaddressed
byhumanservices.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
29.Describetheserotoninsyndrome,oneofthemoreseriousadverseeffectsofbuspirone.
ANSWER: Noanswerprovided.
POINTS: 1
REFERENCES: TheBenzodiazepineReceptorAntagonists(Z-CompoundsorBRAs)
QUESTIONTYPE: Essay
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.05-Describethebenzodiazepinereceptorantagonists
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
UnitedStates-CSHSE.3b-Therangeofpopulationsservedandneedsaddressed
byhumanservices.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM
30.Describesomeofthemorecommonsideeffectsofthenewerhypnotics.
ANSWER: Noanswerprovided.
POINTS: 1
REFERENCES: TheBenzodiazepineReceptorAntagonists(Z-CompoundsorBRAs)
QUESTIONTYPE: Essay
HASVARIABLES: False
LEARNINGOBJECTIVES:DOWE.COCD.19.07.05-Describethebenzodiazepinereceptorantagonists
NATIONALSTANDARDS: UnitedStates-CACREP.3E-Biological,neurological,andphysiologicalfactors
thataffecthumandevelopment,functioning,andbehavior
UnitedStates-CSHSE.3b-Therangeofpopulationsservedandneedsaddressed
byhumanservices.
DATECREATED: 2/21/20181:47PM
DATEMODIFIED: 2/23/20188:34AM